168 related articles for article (PubMed ID: 20882893)
21. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
22. Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer.
Ayhan A; Celik H; Taskiran C; Bozdag G; Aksu T
Eur J Gynaecol Oncol; 2003; 24(3-4):223-32. PubMed ID: 12807228
[TBL] [Abstract][Full Text] [Related]
23. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
24. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
25. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy.
Darai E; Teboul J; Fauconnier A; Scoazec JY; Benifla JL; Madelenat P
Acta Obstet Gynecol Scand; 1998 Apr; 77(4):451-7. PubMed ID: 9598957
[TBL] [Abstract][Full Text] [Related]
26. Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT).
Karlsen NMS; Karlsen MA; Høgdall E; Nedergaard L; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jul; 142(1):50-53. PubMed ID: 27168006
[TBL] [Abstract][Full Text] [Related]
27. Surgical staging of early invasive epithelial ovarian tumors.
Leblanc E; Querleu D; Narducci F; Chauvet MP; Chevalier A; Lesoin A; Vennin P; Taieb S
Semin Surg Oncol; 2000; 19(1):36-41. PubMed ID: 10883022
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic excisional surgery for growing teratoma syndrome of the ovary: case report and literature review.
Shigeta N; Kobayashi E; Sawada K; Ueda Y; Yoshino K; Hori Y; Kimura T
J Minim Invasive Gynecol; 2015; 22(4):668-74. PubMed ID: 25620216
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst.
Papoutsis D; Rodolakis A; Haidopoulos D; Sotiropoulou M; Antsaklis A
Eur J Gynaecol Oncol; 2009; 30(1):103-5. PubMed ID: 19317271
[TBL] [Abstract][Full Text] [Related]
30. Staging procedures in patients with mucinous borderline tumors of the ovary do not reveal peritoneal or omental disease.
De Decker K; Speth S; Ter Brugge HG; Bart J; Massuger LFAG; Kleppe M; Kooreman LFS; Kruitwagen RFPM; Kruse AJ
Gynecol Oncol; 2017 Feb; 144(2):285-289. PubMed ID: 27889017
[TBL] [Abstract][Full Text] [Related]
31. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
32. Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland.
Kipp B; Vidal A; Lenick D; Christmann-Schmid C
J Ovarian Res; 2023 Jan; 16(1):20. PubMed ID: 36691070
[TBL] [Abstract][Full Text] [Related]
33. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up.
Longacre TA; McKenney JK; Tazelaar HD; Kempson RL; Hendrickson MR
Am J Surg Pathol; 2005 Jun; 29(6):707-23. PubMed ID: 15897738
[TBL] [Abstract][Full Text] [Related]
34. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Pregnancy].
Zilliox M; Lallemant M; Thomassin-Naggara I; Ramanah R
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):322-329. PubMed ID: 32004783
[TBL] [Abstract][Full Text] [Related]
35. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
[TBL] [Abstract][Full Text] [Related]
36. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
[TBL] [Abstract][Full Text] [Related]
37. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
38. Micropapillary serous carcinoma of the ovary: case report and review of literature.
Piura B; Rabinovich A; Yanai-Inbar I
Eur J Gynaecol Oncol; 2000; 21(4):374-6. PubMed ID: 11055486
[TBL] [Abstract][Full Text] [Related]
39. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Trillsch F; Mahner S; Vettorazzi E; Woelber L; Reuss A; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Fotopoulou C; Schmalfeldt B; Burges A; Ewald-Riegler N; de Gregorio N; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Kommoss S; Kommoss F; Hauptmann S; du Bois A
Br J Cancer; 2015 Feb; 112(4):660-6. PubMed ID: 25562434
[TBL] [Abstract][Full Text] [Related]
40. [Feasibility and limits of laparoscopic treatment of borderline ovarian tumours].
Fauvet R; Poncelet C; Daraï E
Gynecol Obstet Fertil; 2006 Jun; 34(6):470-8. PubMed ID: 16677839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
